Persistent inflammation may influence neurodegeneration through microglial activation, yet evidence remains hypothesis driven ...

Why does the same virus barely faze one person while sending another to the hospital? New research shows the answer lies in a molecular record etched into our immune cells by both our genes and our ...

Researchers at the University of North Carolina at Chapel Hill have uncovered how chronic inflammation disrupts the immune ...

RNA-based medicine is about to take a huge leap forward thanks to the discovery of extremely short RNA fragments with important anti-inflammatory properties. Professor Michael Gantier's latest ...

Engineering regulatory T cells (Tregs) has emerged as a powerful strategy to achieve durable, antigen-specific immune tolerance for autoimmune and ...

In patients experiencing refractory ischemic digital complications from systemic sclerosis or other diseases, BTX injections are safe and effective.

A genetics‑guided drug, compound 6, targets CARD9 to subtly calm gut inflammation in Crohn’s disease, pointing to safer, ...

The deal gets Lilly access to Orna’s in vivo CAR T technology. The biotech’s lead asset, which has yet to start clinical ...

Eli Lilly (LLY) stock acquiring Orna Therapeutics for up to $2.4 billion to develop circular RNA CAR-T therapies for B ...

Non-communicable diseases such as diabetes, obesity, and metabolic syndrome are rising globally, while infectious diseases, ...

Bringing home a new puppy or kitten is an exciting and joyful experience, but along with the cuddles and playtime comes a ...

Medications targeting the neonatal fragment crystallizable receptor have gained attention due to multiple recent FDA ...